166 related articles for article (PubMed ID: 29530924)
1. Inducible
Ohlsson C; Henning P; Nilsson KH; Wu J; Gustafsson KL; Sjögren K; Törnqvist A; Koskela A; Zhang FP; Lagerquist MK; Poutanen M; Tuukkanen J; Lerner UH; Movérare-Skrtic S
J Endocrinol; 2018 May; 237(2):113-122. PubMed ID: 29530924
[TBL] [Abstract][Full Text] [Related]
2. Induced inactivation of Wnt16 in young adult mice has no impact on osteoarthritis development.
Törnqvist AE; Nilsson KH; Li L; Ohlsson C; Movérare-Skrtic S
PLoS One; 2022; 17(11):e0277495. PubMed ID: 36367882
[TBL] [Abstract][Full Text] [Related]
3. Osteoblast-derived NOTUM reduces cortical bone mass in mice and the
Movérare-Skrtic S; Nilsson KH; Henning P; Funck-Brentano T; Nethander M; Rivadeneira F; Coletto Nunes G; Koskela A; Tuukkanen J; Tuckermann J; Perret C; Souza PPC; Lerner UH; Ohlsson C
FASEB J; 2019 Oct; 33(10):11163-11179. PubMed ID: 31307226
[TBL] [Abstract][Full Text] [Related]
4. Osteocyte- and late osteoblast-derived NOTUM reduces cortical bone mass in mice.
Nilsson KH; Henning P; El Shahawy M; Wu J; Koskela A; Tuukkanen J; Perret C; Lerner UH; Ohlsson C; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2021 May; 320(5):E967-E975. PubMed ID: 33749332
[TBL] [Abstract][Full Text] [Related]
5. WNT16 overexpression partly protects against glucocorticoid-induced bone loss.
Ohlsson C; Nilsson KH; Henning P; Wu J; Gustafsson KL; Poutanen M; Lerner UH; Movérare-Skrtic S
Am J Physiol Endocrinol Metab; 2018 Jun; 314(6):E597-E604. PubMed ID: 29406783
[TBL] [Abstract][Full Text] [Related]
6. Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures.
Movérare-Skrtic S; Henning P; Liu X; Nagano K; Saito H; Börjesson AE; Sjögren K; Windahl SH; Farman H; Kindlund B; Engdahl C; Koskela A; Zhang FP; Eriksson EE; Zaman F; Hammarstedt A; Isaksson H; Bally M; Kassem A; Lindholm C; Sandberg O; Aspenberg P; Sävendahl L; Feng JQ; Tuckermann J; Tuukkanen J; Poutanen M; Baron R; Lerner UH; Gori F; Ohlsson C
Nat Med; 2014 Nov; 20(11):1279-88. PubMed ID: 25306233
[TBL] [Abstract][Full Text] [Related]
7. WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk.
Zheng HF; Tobias JH; Duncan E; Evans DM; Eriksson J; Paternoster L; Yerges-Armstrong LM; Lehtimäki T; Bergström U; Kähönen M; Leo PJ; Raitakari O; Laaksonen M; Nicholson GC; Viikari J; Ladouceur M; Lyytikäinen LP; Medina-Gomez C; Rivadeneira F; Prince RL; Sievanen H; Leslie WD; Mellström D; Eisman JA; Movérare-Skrtic S; Goltzman D; Hanley DA; Jones G; St Pourcain B; Xiao Y; Timpson NJ; Smith GD; Reid IR; Ring SM; Sambrook PN; Karlsson M; Dennison EM; Kemp JP; Danoy P; Sayers A; Wilson SG; Nethander M; McCloskey E; Vandenput L; Eastell R; Liu J; Spector T; Mitchell BD; Streeten EA; Brommage R; Pettersson-Kymmer U; Brown MA; Ohlsson C; Richards JB; Lorentzon M
PLoS Genet; 2012 Jul; 8(7):e1002745. PubMed ID: 22792071
[TBL] [Abstract][Full Text] [Related]
8. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
9. Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.
Alam I; Reilly AM; Alkhouli M; Gerard-O'Riley RL; Kasipathi C; Oakes DK; Wright WB; Acton D; McQueen AK; Patel B; Lim KE; Robling AG; Econs MJ
Calcif Tissue Int; 2017 Apr; 100(4):361-373. PubMed ID: 28013361
[TBL] [Abstract][Full Text] [Related]
10. The effects of estradiol are modulated in a tissue-specific manner in mice with inducible inactivation of ERα after sexual maturation.
Ohlsson C; Farman HH; Gustafsson KL; Wu J; Henning P; Windahl SH; Sjögren K; Gustafsson JÅ; Movérare-Skrtic S; Lagerquist MK
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E646-E654. PubMed ID: 32125882
[TBL] [Abstract][Full Text] [Related]
11. Wnt16 Is Associated with Age-Related Bone Loss and Estrogen Withdrawal in Murine Bone.
Todd H; Galea GL; Meakin LB; Delisser PJ; Lanyon LE; Windahl SH; Price JS
PLoS One; 2015; 10(10):e0140260. PubMed ID: 26451596
[TBL] [Abstract][Full Text] [Related]
12. The bone-sparing effects of estrogen and WNT16 are independent of each other.
Movérare-Skrtic S; Wu J; Henning P; Gustafsson KL; Sjögren K; Windahl SH; Koskela A; Tuukkanen J; Börjesson AE; Lagerquist MK; Lerner UH; Zhang FP; Gustafsson JÅ; Poutanen M; Ohlsson C
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14972-7. PubMed ID: 26627248
[TBL] [Abstract][Full Text] [Related]
13. Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice.
Funck-Brentano T; Nilsson KH; Brommage R; Henning P; Lerner UH; Koskela A; Tuukkanen J; Cohen-Solal M; Movérare-Skrtic S; Ohlsson C
J Endocrinol; 2018 Jul; 238(1):13-23. PubMed ID: 29720540
[TBL] [Abstract][Full Text] [Related]
14. Translational studies provide insights for the etiology and treatment of cortical bone osteoporosis.
Brommage R; Ohlsson C
Best Pract Res Clin Endocrinol Metab; 2018 Jun; 32(3):329-340. PubMed ID: 29779585
[TBL] [Abstract][Full Text] [Related]
15. Multiple Mechanisms Explain Genetic Effects at the CPED1-WNT16 Bone Mineral Density Locus.
Gómez AE; Addish S; Alvarado K; Boatemaa P; Onyali AC; Ramirez EG; Rojas MF; Rai J; Reynolds KA; Tang WJ; Kwon RY
Curr Osteoporos Rep; 2023 Apr; 21(2):173-183. PubMed ID: 36943599
[TBL] [Abstract][Full Text] [Related]
16. Role of WNT16 in the regulation of periosteal bone formation in female mice.
Wergedal JE; Kesavan C; Brommage R; Das S; Mohan S
Endocrinology; 2015 Mar; 156(3):1023-32. PubMed ID: 25521583
[TBL] [Abstract][Full Text] [Related]
17. The androgen receptor is required for maintenance of bone mass in adult male mice.
Wu J; Henning P; Sjögren K; Koskela A; Tuukkanen J; Movérare-Skrtic S; Ohlsson C
Mol Cell Endocrinol; 2019 Jan; 479():159-169. PubMed ID: 30308267
[TBL] [Abstract][Full Text] [Related]
18. A new WNT on the bone: WNT16, cortical bone thickness, porosity and fractures.
Gori F; Lerner U; Ohlsson C; Baron R
Bonekey Rep; 2015; 4():669. PubMed ID: 25987984
[TBL] [Abstract][Full Text] [Related]
19. Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters.
Hendrickx G; Boudin E; Fijałkowski I; Nielsen TL; Andersen M; Brixen K; Van Hul W
Bone; 2014 Feb; 59():57-65. PubMed ID: 24185276
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice.
Alam I; Oakes DK; Reilly AM; Billingsley C; Sbeta S; Gerard-O'Riley RL; Acton D; Sato A; Bellido T; Econs MJ
JBMR Plus; 2019 Apr; 3(4):e10084. PubMed ID: 31044183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
